Le Lézard
Classified in: Health
Subject: SVY

US Demand for Analytical Instruments to Reach $50.2 Billion in 2021


CLEVELAND, Dec. 12, 2017 /PRNewswire/ -- US analytical instrument demand is forecast to total $50.2 billion in 2021, according to Analytical Instruments: United States, a report recently released by Freedonia Focus Reports. Increased research and development (R&D) funding will drive gains over the forecast period.

Freedonia Group logo

More information about the report is available at
https://www.freedoniafocusreports.com/Analytical-Instruments-United-States-FF80013/

Demand for laboratory instruments is projected to grow the fastest of any discrete segment and remain the largest through 2021. Gains will be driven by increasing R&D funding, particularly for the purpose of developing new pharmaceuticals as older patents expire. Shipments of analytical instruments from facilities in the US are also projected to grow through 2021, driven by rising domestic investment and R&D expenditures in developing countries.

These and other key insights are featured in Analytical Instruments: United States. This report forecasts US analytical instrument demand and shipments in US dollars at the manufacturer level to 2021. Total demand and shipments are segmented by product in terms of:

To illustrate historical trends, total demand, total shipments, the various segments, and trade are provided in annual series from 2006 to 2016.

About Freedonia Focus Reports
Each month, The Freedonia Group ? a division of MarketResearch.com ? publishes over 20 new or updated Freedonia Focus Reports, providing fresh, unbiased analysis on a wide variety of markets and industries. Published in 20-30 pages, Focus Report coverage ranges from raw materials to finished manufactured goods and related services such as freight and construction. Additional Healthcare & Biotechnology reports can be purchased at Freedonia Focus Reports or MarketResearch.com.

Analysis is intended to guide the busy reader through pertinent topics in rapid succession, including:

Press Contact:
Corinne Gangloff
+1 440.684.9600
[email protected]

 

SOURCE The Freedonia Group


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: